Description: PharmaSGP Holding SE manufactures over-the-counter drugs, and other healthcare products in Germany. The company's pharmaceutical products include Baldriparan for the treatment of sleep disorders; Spalt, Formigran, and Kamol massage cream for the treatment of different pain conditions; RubaXX pharmaceutical drops for the treatment of rheumatic pain in bones, tendons, and muscles; Restaxil pharmaceutical drops for the treatment of nerve pain in neck and back; Fulminan, a beauty drink for problems in areas, such as eye area, buttocks, or thighs; DESEO pharmaceutical drops for sexual weakness; Neradin, a drug for sexual dysfunction; and TAUMEA, a drug for the treatment of vertigo. It also offers products for the treatment of chronic indications, including pain and other age-related ailments. The company sells its products through pharmacies and wholesalers. It exports its products to European countries comprising Austria, Italy, Belgium, Spain, and France. The company was founded in 2012 and is based in Gräfelfing, Germany.
Home Page: pharmasgp.com
Lochhamer Schlag 21
Gräfelfing,
82166
Germany
Phone:
89 85 89 639 150
Officers
| Name | Title |
|---|---|
| Ms. Natalie Weigand | CEO & Member of Management Board |
| Mr. Michael Rudolf | CFO & Member of Management Board |
Exchange: XETRA
Country: DE : Germany
Currency: Euro (€)
| Forward PE: | 23.0947 |
|---|---|
| Trailing PE: | 25.8511 |
| Price-to-Book MRQ: | 11.0595 |
| Price-to-Sales TTM: | 3.7389 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 66 |